CB Insights June 17, 2019
Rachel Shope

D2C genomics companies like 23andMe are beginning to expand their product offerings by partnering with companies in other industries.

As a result, synergies between these D2C companies and those of other industries are also starting to take hold. For example, last month 23andMe announced that it’s partnering with travel tech company Airbnb for heritage tourism.

It’s one of the many ways in which these companies are able to extend their product offerings and create more value for their customers.

23andMe, in particular, has had great success here — especially in healthcare —...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Patient / Consumer, Physician, Precision Medicine, Provider, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article